Table 3 Patient Rated Inventory of Side Effects (PRISE) counts of symptoms (rated tolerable or distressing) 60 mins post oral ketamine administration by treatment week (n = 32).

From: Low dose oral ketamine treatment in chronic suicidality: An open-label pilot study

Treatment week

1

2

3

4

5

6

Ntolerable/Ndistressing

Decreased energy

17/14

23/7

21/7

21/8

18/7

23/3

Fatigue

18/12

20/11

18/10

20/8

18/7

19/7

Anxiety

11/18

21/7

20/9

23/3

15/9

21/3

Poor concentration

16/13

22/6

19/7

18/7

20/4

19/2

Restlessness

19/5

15/3

17/4

14/3

15/3

16/1

General malaise discomfort

14/7

18/3

14/2

10/3

13/2

12/2

Dry mouth

17/1

15/3

18/2

19/2

15/2

18/1

Headache

16/1

19/2

15/3

14/1

15/1

12/3

Dizziness on standing

15/1

12/0

11/0

13/0

11/1

11/0

Tremors

13/2

10/1

9/2

11/1

9/1

9/0

Dry skin

13/0

12/0

12/0

14/0

13/0

13/0

Dizziness

13/0

10/0

13/0

9/0

9/0

11/0

Ringing in ears

10/2

8/0

7/1

5/1

5/1

7/1

Palpitation

10/1

12/0

9/1

8/0

8/0

6/0

Itching

10/0

8/0

8/0

8/0

7/0

5/1

Frequent urination

9/0

7/1

8/0

10/0

7/1

11/1

Blurred vision

8/0

3/0

5/0

6/0

6/0

7/0

Increased perspiration

8/0

4/0

4/0

4/0

3/0

3/1

Poor coordination

7/1

3/1

7/0

7/1

10/1

7/1

Rash

7/0

4/0

5/0

5/0

5/0

4/0

Nausea vomiting

6/0

7/1

7/1

10/0

6/1

11/0

Chest pain

4/1

3/0

1/0

2/0

2/0

5/0

Diarrhoea

4/0

6/1

6/0

4/0

5/0

5/0

Other

3/1

3/2

0/0

2/1

3/0

1/1

Constipation

3/0

7/0

5/0

7/0

9/0

9/0

Difficulty urinating

2/0

2/0

2/0

2/0

2/0

1/0

Painful urination

1/0

1/0

1/0

1/0

2/0

2/0

  1. Ntolerable/Ndistressing is the number of individuals that reported the symptom to be tolerable or distressing.